-
1
-
-
0024397491
-
Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients
-
Hajto T, Hostanska K, Gabius H-J. Modulatory potency ofthe β-galactoside-specific lectin from mistletoe extract (Iscador)on the host defense system in vivo in rabbits and patients.Cancer Res 1989;49:4803-4808. (Pubitemid 19213628)
-
(1989)
Cancer Research
, vol.49
, Issue.17
, pp. 4803-4808
-
-
Hajto, T.1
Hostanska, K.2
Gabius, H.-J.3
-
2
-
-
80054851914
-
A plant lectin,Viscum album agglutinin-I (VAA-I), stimulates cellular parametersof natural immunity in vivo and induces cytokinegene expression and apoptosis in cultures of peripheral bloodmononuclear cells in vitro
-
Hostanska K, Hajto T, Spagnoli GC, Saller R. A plant lectin,Viscum album agglutinin-I (VAA-I), stimulates cellular parametersof natural immunity in vivo and induces cytokinegene expression and apoptosis in cultures of peripheral bloodmononuclear cells in vitro. Nat Immun 1996-1997;15:196-201.
-
(1996)
Nat Immun
, vol.15
, pp. 196-201
-
-
Hostanska, K.1
Hajto, T.2
Spagnoli, G.C.3
Saller, R.4
-
3
-
-
0031794944
-
Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo
-
DOI 10.1159/000069428
-
Hajto T, Hostanska K, Weber K, et al. Effect of a recombinantlectin, Viscum album agglutinin (rVAA) on secretion of interleukin-12 in cultured human peripheral blood mononuclearcells and on NK-cell-mediated cytotoxicity of ratsplenocytes in vitro and in vivo. Nat Immun 1998;16:34-46. (Pubitemid 28499445)
-
(1998)
Natural Immunity
, vol.16
, Issue.1
, pp. 34-46
-
-
Hajto, T.1
Hostanska, K.2
Weber, K.3
Zinke, H.4
Fischer, J.5
Mengs, U.6
Lentzen, H.7
Saller, R.8
-
4
-
-
0025313821
-
Increased secretion of tumor necrosis factor α, interleukin 1, and interleukin 6 by human mononuclear cells exposed to β-galactoside-specific lectin from clinically applied mistletoe extract
-
Hajto T, Hostanska K, Frei K, et al. Increased secretion oftumor necrosis factor-α, interleukin-1 and interleukin-6 byhuman mononuclear cells exposed to β-galactoside-specificmistletoe lectin. Cancer Res 1990;50:3322-3326. (Pubitemid 20190139)
-
(1990)
Cancer Research
, vol.50
, Issue.11
, pp. 3322-3326
-
-
Hajto, T.1
Hostanska, K.2
Frei, K.3
Rordorf, C.4
Gabius, H.-J.5
-
5
-
-
0036111768
-
Mistletoe viscotoxins increase natural killer cell-mediated cytotoxicity
-
DOI 10.1046/j.1432-1033.2002.02932.x
-
Tabiasco J, Pont F, Fourniè J, Vercellone A. Mistletoe viscotoxinsincrease natural killer cell-mediated cytotoxicity. Eur JBiochem 2002;269:2591-2600. (Pubitemid 34539288)
-
(2002)
European Journal of Biochemistry
, vol.269
, Issue.10
, pp. 2591-2600
-
-
Tabiasco, J.1
Pont, F.2
Fournie, J.-J.3
Vercellone, A.4
-
6
-
-
0026653444
-
Immunomodulatory activity of a peptideisolated from viscum album extract (NSC 635089)
-
Kuttan G, Kuttan R. Immunomodulatory activity of a peptideisolated from Viscum album extract (NSC 635089). ImmunolInvest 1992;21:285-296.
-
(1992)
ImmunolInvest
, vol.21
, pp. 285-296
-
-
Kuttan, G.1
Kuttan, R.2
-
7
-
-
0032787382
-
Influence ofpolysaccharides from Viscum album L on human lymphocytesmonocytes and granulocytes in vitro
-
Stein GM, Edlund U, Büssing A, Schitzel M. Influence ofpolysaccharides from Viscum album L on human lymphocytes,monocytes and granulocytes in vitro. Anticancer Res1999;19:3907-3914.
-
(1999)
Anticancer Res
, vol.19
, pp. 3907-3914
-
-
Stein, G.M.1
Edlund, U.2
Büssing, A.3
Schitzel, M.4
-
8
-
-
0031010983
-
Oligoclonal in vitro response of CD4 T cells to vesicles of mistletoe extracts in mistletoe-treated cancer patients
-
DOI 10.1007/s002620050367
-
Fischer S, Scheffler A, Kabelitz D. Oligoclonal in vitro responseof CD4 T cells to vesicles of mistletoe extracts inmistletoe-treated cancer patients. Cancer Immunol Immunother1997;44:150-156. (Pubitemid 27278387)
-
(1997)
Cancer Immunology Immunotherapy
, vol.44
, Issue.3
, pp. 150-156
-
-
Fischer, S.1
Scheffler, A.2
Kabelitz, D.3
-
9
-
-
0020997777
-
Differences in toxicity andantigenicity between mistletoe lectin I and viscotoxin A3
-
Franz H, Kindt A, Eifler R, et al. Differences in toxicity andantigenicity between mistletoe lectin I and viscotoxin A3.Biomed Biochem Acta 1983;42:K21-K25.
-
(1983)
Biomed Biochem Acta
, vol.42
-
-
Franz, H.1
Kindt, A.2
Eifler, R.3
-
10
-
-
11144352711
-
Apoptosis inducing activity of viscin, a lipophilic extract from Viscum album L
-
DOI 10.1211/0022357055083
-
Urech K, Scher JM, Hostanska K, Becker H. Apoptosis inducingactivity of viscin, a lipophilic extract from Viscumalbum L. J Pharmacy Pharmacol 2005;57:101-109. (Pubitemid 40030108)
-
(2005)
Journal of Pharmacy and Pharmacology
, vol.57
, Issue.1
, pp. 101-109
-
-
Urech, K.1
Scher, J.M.2
Hostanska, K.3
Becker, H.4
-
12
-
-
25844444123
-
Oncopharmacological perspectives of a plant lectin (Viscum album agglutinin-I): Overview of recent results from in vitro experiments and in vivo animal models, and their possible relevance for clinical applications
-
DOI 10.1093/ecam/neh058
-
Hajto T, Hostanska K, Berki T, et al. Oncopharmacologicalperspectives of a plant lectin (Viscum album agglutinin-I):Overview of recent results from in vitro experiments and invivo animal models, and their possible relevance for clinicalapplications. eCAM 2005;2:59-67. (Pubitemid 41399515)
-
(2005)
Evidence-based Complementary and Alternative Medicine
, vol.2
, Issue.1
, pp. 59-67
-
-
Hajto, T.1
Hostanska, K.2
Berki, T.3
Palinkas, L.4
Boldizsar, F.5
Nemeth, P.6
-
13
-
-
80054855086
-
Enhancementof antitumor activity of clinical applied mistletoe extracts(Iscador) by lectin optimization
-
In: Stacher A, ed, Vienna: Facultas Publisher
-
Hajto T, Hostanska K, Fornalski M, Kirsch A. Enhancementof antitumor activity of clinical applied mistletoe extracts(Iscador) by lectin optimization. In: Stacher A, ed. EntireMedicine. Vienna: Facultas Publisher, 1991:489-491.
-
(1991)
EntireMedicine
, pp. 489-491
-
-
Hajto, T.1
Hostanska, K.2
Fornalski, M.3
Kirsch, A.4
-
14
-
-
0025772039
-
Antitumoractivity of β-galactoside specific mistletoe lectin by clinicalapplication of mistletoe extracts (Iscador)
-
Hajto T, Hostanska K, Fornalski M, Kirsch A. Antitumoractivity of β-galactoside specific mistletoe lectin by clinicalapplication of mistletoe extracts (Iscador). Deutsch ZschrOnkol 1991;23:1-6.
-
(1991)
Deutsch ZschrOnkol
, vol.23
, pp. 1-6
-
-
Hajto, T.1
Hostanska, K.2
Fornalski, M.3
Kirsch, A.4
-
15
-
-
67949100782
-
Unexpected differentbinding of mistletoe lectins from plant extracts to immobilizedlactose and N-acetylgalactosamine
-
Hajto T, Fodor K, Aponyi I, et al. Unexpected differentbinding of mistletoe lectins from plant extracts to immobilizedlactose and N-acetylgalactosamine. Anal ChemInsights 2007;2:43-50.
-
(2007)
Anal ChemInsights
, vol.2
, pp. 43-50
-
-
Hajto, T.1
Fodor, K.2
Aponyi, I.3
-
16
-
-
3042656476
-
Local and distant recurrences in rectal cancer patients arepredicted by the nonspecific immune response; specific immuneresponse has only a systemic effect.A histopathologicaland immunohistochemical study
-
Nagtegaal ID, Klein-Kranenbarg E, Mulder-Stapel A, et al.Local and distant recurrences in rectal cancer patients arepredicted by the nonspecific immune response; specific immuneresponse has only a systemic effect. A histopathologicaland immunohistochemical study. BMC Cancer 2001;1:7-16.
-
(2001)
BMC Cancer
, vol.1
, pp. 7-16
-
-
Nagtegaal, I.D.1
Klein-Kranenbarg, E.2
Mulder-Stapel, A.3
-
17
-
-
0027485675
-
Natural history of HLA expression during tumour development
-
DOI 10.1016/0167-5699(93)90264-L
-
Garrido F, Cabrera T, Concha A, Glew S, et al. Naturalhistory of HLA expression during tumour development.Immunol Today 1993;14:491-499. (Pubitemid 23301000)
-
(1993)
Immunology Today
, vol.14
, Issue.10
, pp. 491-499
-
-
Garrido, F.1
Cabrera, T.2
Concha, A.3
Glew, S.4
Ruiz-Cabello, F.5
Stern, P.L.6
-
18
-
-
0034923391
-
Blood monocytes and tumor-associated macrophages in human cancer: Differences in activation levels
-
Baskic D, Acimovic L, Samardzic G, et al. Blood monocytesand tumor-associated macrophages in human cancer: Differencesin activation levels. Neoplasma 2001;48:169-174. (Pubitemid 32678680)
-
(2001)
Neoplasma
, vol.48
, Issue.3
, pp. 169-174
-
-
Baskic, D.1
Acimovic, L.2
Samardzic, G.3
Vujanovic, N.L.4
Arsenijevic, N.N.5
-
19
-
-
65249138393
-
Myeloid derived suppressorcells linking in inflammation and cancer
-
Ostrand-Rosenberg S, Sinka P. Myeloid derived suppressorcells linking in inflammation and cancer. J Immunol 2009;182:4499-4506.
-
(2009)
J Immunol
, vol.182
, pp. 4499-4506
-
-
Ostrand-Rosenberg, S.1
Sinka, P.2
-
20
-
-
34548499681
-
Inflammation and cancer: The macrophageconnection
-
Mantovani A. Inflammation and cancer: The macrophageconnection. Medicina (Buenos Aires) 2007;67(suppl II):32-34.
-
(2007)
Medicina (Buenos Aires)
, vol.67
, Issue.SUPPL. 2
, pp. 32-34
-
-
Mantovani, A.1
-
21
-
-
0035207272
-
+ T cells
-
Sanchez-Torres C, Garcia-Romo GS, Cornejo-Cortes MA,et al. CD16 + and CD16- human blood monocyte subsetsdifferentiate in vitro to dendritic cells with different abilitiesto stimulate CD4+ T cells. Int Immunol 2001;13:1571-1581. (Pubitemid 33133884)
-
(2001)
International Immunology
, vol.13
, Issue.12
, pp. 1571-1581
-
-
Sanchez-Torres, C.1
Garcia-Romo, G.S.2
Cornejo-Cortes, M.A.3
Rivas-Carvalho, A.4
Sanchez-Schmitz, G.5
-
22
-
-
56849090964
-
The role of NKT cells in tumorimmunology
-
Terabe M, Berzofsky JA. The role of NKT cells in tumorimmunology. Adv Cancer Res 2008;101:277-348.
-
(2008)
Adv Cancer Res
, vol.101
, pp. 277-348
-
-
Terabe, M.1
Berzofsky, J.A.2
-
23
-
-
63849171612
-
Immunotherapy forcancer: Promoting innate immunity
-
Lotfi R, Schrezenmeier H, Lotze MT. Immunotherapy forcancer: Promoting innate immunity. Front Biosci 2009;14:818-832.
-
(2009)
Front Biosci
, vol.14
, pp. 818-832
-
-
Lotfi, R.1
Schrezenmeier, H.2
Lotze, M.T.3
-
24
-
-
0036668101
-
Preferential binding of theanticancer drug rViscumin (recombinant mistletoe lectin) toterminally α2-6-sialylated neolacto-series gangliosides
-
Müthing J, Burg M, Möckel B. Preferential binding of theanticancer drug rViscumin (recombinant mistletoe lectin) toterminally α2-6-sialylated neolacto-series gangliosides. Glycobiol2002;12:485-497.
-
(2002)
Glycobiol
, vol.12
, pp. 485-497
-
-
Müthing, J.1
Burg, M.2
Möckel, B.3
-
25
-
-
12144288364
-
Mistletoe Lectin I Is A Sialic Acid-Specific Lectin with Strict Preference to Gangliosides and Glycoproteins with Terminal Neu5Acα2- 6Galβ 1-4GlcNAc Residues
-
DOI 10.1021/bi0301892
-
Müthing J, Meisen I, Bulau P, et al. Mistletoe lectin I is asialic acid-specific lectin with strict preference to gangliosidesand glycoproteins with terminal Neu5Ac alpha2-6Gal beta 1-4GlcNAc residues. Biochemistry 2004;43:2996-3007. (Pubitemid 38352250)
-
(2004)
Biochemistry
, vol.43
, Issue.11
, pp. 2996-3007
-
-
Muthing, J.1
Meisen, I.2
Bulau, P.3
Langer, M.4
Witthohn, K.5
Lentzen, H.6
Neumann, U.7
Peter-Katalinic, J.8
-
26
-
-
79955082840
-
Difficulties andperspectives of immunomodulatory therapy with mistletoelectins and standardized mistletoe extracts in evidencebased medicine
-
Hajtò T, Fodor K, Perjèsi P, Nèmeth P. Difficulties andperspectives of immunomodulatory therapy with mistletoelectins and standardized mistletoe extracts in evidencebased medicine. Evid Based Complement Alternat Med2011;2011;298972.
-
(2011)
Evid Based Complement Alternat Med
, pp. 298-972
-
-
Hajtò, T.1
Fodor, K.2
Perjèsi, P.3
Nèmeth, P.4
-
27
-
-
3042955271
-
β-Galactoside-specificlectin from clinically applied mistletoe extract reduces tumorgrowth by augmentation of host defense system
-
Hajto T, Hostanska K, Steinberg F. β-Galactoside-specificlectin from clinically applied mistletoe extract reduces tumorgrowth by augmentation of host defense system. Blut 1990;61:164.
-
(1990)
Blut
, vol.61
, pp. 164
-
-
Hajto, T.1
Hostanska, K.2
Steinberg, F.3
-
28
-
-
33749257279
-
Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma
-
DOI 10.1016/j.canlet.2005.11.016, PII S0304383505010025
-
Duong van Huyen JP, Delignat S, Bayry J, et al. Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoeextracts in B16 mouse melanoma. Cancer Lett 2006;243:32-37. (Pubitemid 44485319)
-
(2006)
Cancer Letters
, vol.243
, Issue.1
, pp. 32-37
-
-
Duong Van Huyen, J.-P.1
Delignat, S.2
Bayry, J.3
Kazatchkine, M.D.4
Bruneval, P.5
Nicoletti, A.6
Kaveri, S.V.7
-
29
-
-
0032408630
-
Low-grade endometrial stromalsarcoma preoperative treatment with Depo-Lupron andMegace
-
Scribner DRI,Walker IL Low-grade endometrial stromalsarcoma preoperative treatment with Depo-Lupron andMegace. Gynecol Oncol 1998;71:458-460
-
(1998)
Gynecol Oncol
, vol.71
, pp. 458-460
-
-
Scribner, D.R.I.1
Walker, I.L.2
-
30
-
-
16544384220
-
Treatment of endometrial stromal sarcomawith a gonadotropin-releasing hormone analogue
-
Burke C, Hickey K. Treatment of endometrial stromal sarcomawith a gonadotropin-releasing hormone analogue.Obstet Gynecol 2004;104:1182-1184.
-
(2004)
Obstet Gynecol
, vol.104
, pp. 1182-1184
-
-
Burke, C.1
Hickey, K.2
-
31
-
-
3543074572
-
Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor
-
DOI 10.1016/j.ygyno.2004.03.025, PII S0090825804001982
-
Leiser AL, Hamid AM, Blanchard R. Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cordstromal component treated with progestin and aromataseinhibitor. Gynecol Oncol 2004;94:567-571. (Pubitemid 39024569)
-
(2004)
Gynecologic Oncology
, vol.94
, Issue.2
, pp. 567-571
-
-
Leiser, A.L.1
Hamid, A.M.2
Blanchard, R.3
|